SCHEMBL31469255

SCHEMBL31469255

Cc1cc(=O)n(-c2ccccc2F)[nH]1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.66
MAPT P10636 5/20 0.66
KDM4E B2RXH2 4/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
NOX4 Q9NPH5 1/20 0.52
KMT2A Q03164 5/20 0.48
GAA P10253 2/20 0.47
HTT P42858 2/20 0.47
MEN1 O00255 2/20 0.47
CTSA P10619 8/20 0.47
ALKBH3 Q96Q83 1/20 0.47
CYP3A4 P08684 1/20 0.46
LMNA P02545 1/20 0.45
RECQL P46063 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
MGLL Q99685 1/20 0.42
ALPL P05186 1/20 0.41
NOTUM Q6P988 1/20 0.40
HCAR1 Q9BXC0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17260080 1.00 ALDH1A1 (0.66) ALDH1A1MAPTKDM4ESMN1; SMN2NOX4
SCHEMBL5527948 0.82 MAPT (0.70) ALDH1A1MAPTKDM4ESMN1; SMN2NOX4
SCHEMBL20268413 0.81 ALDH1A1 (0.51) ALDH1A1MAPTKDM4ESMN1; SMN2NOX4
SCHEMBL4029048 0.79 ALDH1A1 (1.00) ALDH1A1MAPTKDM4ESMN1; SMN2NOX4
SCHEMBL9765242 0.79 MAPT (0.66) ALDH1A1MAPTKDM4ESMN1; SMN2KMT2A
SCHEMBL9455149 0.79 ALDH1A1 (0.66) ALDH1A1MAPTKDM4ESMN1; SMN2KMT2A
SCHEMBL10743336 0.79 ALDH1A1 (0.56) ALDH1A1MAPTKDM4ESMN1; SMN2NOX4
SCHEMBL1564411 0.77 MAPT (0.62) ALDH1A1MAPTKDM4ESMN1; SMN2KMT2A
SCHEMBL5528033 0.77 ALDH1A1 (0.62) ALDH1A1MAPTKDM4ESMN1; SMN2NOX4
SCHEMBL11435207 0.76 ALDH1A1 (0.60) ALDH1A1MAPTKDM4ESMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122029158-A EGFR inhibitors 缆图药品公司 2026-05-12 CN disclosed
WO-2025080784-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2025-04-17 WO disclosed